EBR Systems, Inc. announced the appointment of Michael Hendrickson as Chief Operating Officer (COO) and Steve Sandweg as Chief Commercial Officer (CCO), and the promotion of Madhuri Bhat to Chief Regulatory Officer (CRO). Michael has joined EBR's senior management team as COO and has over 25 years of medical device product development and manufacturing experience. Michael was COO at Ceterix Orthopaedics (Ceterix) where he led the development of the NOVOSTITCH Pro Meniscal Repair System. Steve has joined EBR's senior management team as CCO and will be responsible for all commercialization activities, including global field operations, SOLVE-CRTclinical trial enrollment, marketing, and preparation activities for commercial launch. Most recently, Steve served as General Manager for Keystone Heart, a Venus Medtech Company, where he was responsible for all clinical, commercial, quality, regulatory and compliance activities within the U.S and Europe. In addition, Madhuri has been promoted to CRO and will be responsible for EBR's global regulatory, compliance, clinical, and quality functions. She joined EBR in February 2019, and most recently served as Senior Vice President of Regulatory & Compliance, Quality, and Clinical. Madhuri has over 20 years of experience in public affairs, public policy, clinical, quality assurance and regulatory roles in medical device companies.
EBR Systems, Inc. is engaged in the treatment for patients suffering from cardiac rhythm diseases by providing physiological stimulation through endocardiac pacing. The Company is engaged in developing and commercializing Wireless Stimulation Endocardially (WiSE), an implantable, cardiac pacing device able to provide stimulation to endocardial (inside the heart) heart tissue for the correction of heart rhythm conditions without requiring the use of leads. WiSE offers leadless solutions for LV Pacing, including cardiac resynchronization therapy (CRT) and conduction system pacing (CSP). The Company also offers CRT devices through the CRM subsegment under the brand names, including Visionist X4 CRT-P, Valitude X4 (CRT-P), Momentum CRT-D, Resonate X4 CRT-D, and Vigilant X4 CRT-D, among others. The Company operates various subsidiaries, which include EBR Systems (AUST) Pty. Ltd. and EBR Systems (UK) Limited, which establish clinical trials in Australia and the United Kingdom, respectively.
EBR SYSTEMS, INC. 
